Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Glaukos Corp (NY: GKOS )

75.25 -0.95 (-1.25%)
Official Closing Price Updated: 7:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 783,176
Open 76.26
Bid (Size) 74.78 (1)
Ask (Size) 75.75 (1)
Prev. Close 76.20
Today's Range 74.20 - 76.26
52wk Range 40.45 - 80.28
Shares Outstanding 48,649,562
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
8 Analysts Have This to Say About Glaukos
Via Benzinga
Glaukos Announces Participation in Wells Fargo Healthcare Conference
From Glaukos Corporation
Via Business Wire

Performance

YTD
+71.49%
+71.49%
1 Month
+0.48%
+0.48%
3 Month
+7.98%
+7.98%
6 Month
+51.99%
+51.99%
1 Year
+41.82%
+41.82%

More News

Read More
Glaukos Announces Second Quarter 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos's Earnings Outlook
Via Benzinga
Analyst Ratings for Glaukos
Via Benzinga
Glaukos Poised To Surpass Expectations And Raise Outlook In Q2 FY23, Fueled By iStent And iAccess Launches: Analyst
Via Benzinga
Where Glaukos Stands With Analysts
Via Benzinga
Stifel Maintains Buy Rating for Glaukos: Here's What You Need To Know
Via Benzinga
8 Analysts Have This to Say About Glaukos
Via Benzinga
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
From Glaukos Corporation
Via Business Wire
These 2 Soaring Stocks Finished the Week Strong
Via The Motley Fool
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
Via Benzinga
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
From Glaukos Corporation
Via Business Wire
Analyst Expectations for Glaukos's Future
Via Benzinga
Glaukos: Q1 Earnings Insights
Via Benzinga
Expert Ratings for Glaukos
Via Benzinga
Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Via Benzinga
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
From Glaukos Corporation
Via Business Wire
Glaukos Announces Participation in the William Blair Growth Stock Conference
From Glaukos Corporation
Via Business Wire
Tyson Foods, PayPal And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR
From Glaukos Corporation
Via Business Wire
Glaukos Announces First Quarter 2023 Financial Results
From Glaukos Corporation
Via Business Wire
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting
From Glaukos Corporation
Via Business Wire
Glaukos Announces the Release of its 2022 Sustainability Report
From Glaukos Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.